Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 1/2024

08.09.2022 | Originalien

Investigating performance-based hand functions in patients with systemic sclerosis

verfasst von: Emre Alp Akatay, Deniz Bayraktar, Eda Otman, Oguz Ustun, Idil Kurut Aysin, Devrim Can Sarac, Busranur Atalay, Irem Ramazanoglu, Ilyas Tekin, Tugba Kurum, Sercan Gucenmez, Mustafa Ozmen, Servet Akar

Erschienen in: Zeitschrift für Rheumatologie | Sonderheft 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Objective

Systemic sclerosis (SSc) is a connective tissue disorder characterized by collagen deposits in various organs. Skin involvement is one of the most common symptoms and along with vascular damage, may deteriorate hand functions. However, the status of hand functions has generally been investigated using patient-reported measures in patients with SSc. The aim of the present study was to investigate performance-based hand functions in patients with SSc using the Sollerman Hand Function Test (SHFT).

Methods

A total of 39 patients with SSc (33 females) were included in the study. Twenty-four patients were classified as limited cutaneous SSc (lcSSc), while 15 patients were classified as diffuse cutaneous SSc (dcSSc). Hand-related physical characteristics were evaluated using the Modified Hand Mobility in Scleroderma Test, grip strength, and pinch strengths. The Duruoz Hand Index (Cochin Hand Functional Disability Scale), Disability of Arm, Shoulder, and Hand Questionnaire, Health Assessment Questionnaire, and Scleroderma Health Assessment Questionnaire were used as patient-reported measures. Performance-based hand functions were evaluated using SHFT.

Results

No significant differences were observed between lcSSc and dcSSc subtypes regarding performance-based and patient-reported hand functions (p > 0.05). SHFT scores significantly correlated with hand-related physical characteristics and patient-reported hand functions (p < 0.05). The highest correlation was determined between SHFT and the Duruoz Hand Index (rho: −0.652, p < 0.001).

Conclusion

According to our results, performance-based hand functions seem not to be affected by disease subtype. Performance-based hand functions may partially be captured by the patient-reported outcomes, especially the Duruoz Hand Index, in patients with SSc.
Literatur
2.
Zurück zum Zitat Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989–2003CrossRefPubMed Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989–2003CrossRefPubMed
3.
4.
Zurück zum Zitat Brower LM, Poole JL (2004) Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 51:805–809CrossRefPubMed Brower LM, Poole JL (2004) Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma). Arthritis Rheum 51:805–809CrossRefPubMed
5.
Zurück zum Zitat Poole JL, Gallegos M, O’Linc S (2000) Reliability and validity of the Arthritis Hand Function Test in adults with systemic sclerosis (scleroderma). Arthritis Care Res 13:69–73CrossRefPubMed Poole JL, Gallegos M, O’Linc S (2000) Reliability and validity of the Arthritis Hand Function Test in adults with systemic sclerosis (scleroderma). Arthritis Care Res 13:69–73CrossRefPubMed
6.
Zurück zum Zitat Sollerman C, Ejeskär A (1995) Sollerman hand function test. A standardised method and its use in tetraplegic patients. Scand J Plast Reconstr Surg Hand Surg 29:167–176CrossRefPubMed Sollerman C, Ejeskär A (1995) Sollerman hand function test. A standardised method and its use in tetraplegic patients. Scand J Plast Reconstr Surg Hand Surg 29:167–176CrossRefPubMed
7.
Zurück zum Zitat van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747–1755CrossRefPubMed
8.
Zurück zum Zitat Khanna D, Furst DE, Clements PJ et al (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2:11–18CrossRefPubMed Khanna D, Furst DE, Clements PJ et al (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J Scleroderma Relat Disord 2:11–18CrossRefPubMed
9.
Zurück zum Zitat Tore NG, Sari F, Sarac DC et al (2020) Inter-rater reliability of modified hand mobility in scleroderma test. Int J Rheum Dis 23:203–206CrossRefPubMed Tore NG, Sari F, Sarac DC et al (2020) Inter-rater reliability of modified hand mobility in scleroderma test. Int J Rheum Dis 23:203–206CrossRefPubMed
10.
Zurück zum Zitat Mackin EJ, Callahan AD, Osterman AL, Skirven TM, Schneider L (2002) Hunter, Mackin & Callahan’s rehabilitation of the hand and upper extremity, 5th edn. Mosby, St Louis, pp 263–284 Mackin EJ, Callahan AD, Osterman AL, Skirven TM, Schneider L (2002) Hunter, Mackin & Callahan’s rehabilitation of the hand and upper extremity, 5th edn. Mosby, St Louis, pp 263–284
11.
Zurück zum Zitat Duruöz MT, Poiraudeau S, Fermanian J et al (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23:1167–1172PubMed Duruöz MT, Poiraudeau S, Fermanian J et al (1996) Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol 23:1167–1172PubMed
12.
Zurück zum Zitat Duger T, Yakut E, Oksuz C, Yorukan S, Semin Bilgutay B, Ayhan C, Leblebicioglu G, Kayıhan H, Kırdı N, Yakut Y, Guler C (2006) Reliability and validity of the Turkish version of the disabilities of the arm, shoulder and hand (DASH) questionnaire. Fizyoterapi Rehabilitasyon 17:99–107 Duger T, Yakut E, Oksuz C, Yorukan S, Semin Bilgutay B, Ayhan C, Leblebicioglu G, Kayıhan H, Kırdı N, Yakut Y, Guler C (2006) Reliability and validity of the Turkish version of the disabilities of the arm, shoulder and hand (DASH) questionnaire. Fizyoterapi Rehabilitasyon 17:99–107
13.
Zurück zum Zitat Temiz Karadag D, Karakas F, Tekeoglu S et al (2019) Validation of Turkish version of the Scleroderma health assessment questionnaire. Clin Rheumatol 38:1917–1923CrossRefPubMed Temiz Karadag D, Karakas F, Tekeoglu S et al (2019) Validation of Turkish version of the Scleroderma health assessment questionnaire. Clin Rheumatol 38:1917–1923CrossRefPubMed
14.
Zurück zum Zitat Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107CrossRefPubMed Sandqvist G, Eklund M, Akesson A, Nordenskiöld U (2004) Daily activities and hand function in women with scleroderma. Scand J Rheumatol 33:102–107CrossRefPubMed
15.
Zurück zum Zitat Erol K, Gok K, Cengiz G, Ozgocmen S (2018) Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables. Int J Rheum Dis 21:249–252CrossRefPubMed Erol K, Gok K, Cengiz G, Ozgocmen S (2018) Hand functions in systemic sclerosis and rheumatoid arthritis and influence on clinical variables. Int J Rheum Dis 21:249–252CrossRefPubMed
16.
Zurück zum Zitat Schouffoer AA, van der Giesen FJ, Beaart-van de Voorde LJ et al (2016) Validity and responsiveness of the Michigan hand questionnaire in patients with systemic sclerosis. Rheumatology (Oxford) 55:1386–1393CrossRefPubMed Schouffoer AA, van der Giesen FJ, Beaart-van de Voorde LJ et al (2016) Validity and responsiveness of the Michigan hand questionnaire in patients with systemic sclerosis. Rheumatology (Oxford) 55:1386–1393CrossRefPubMed
17.
Zurück zum Zitat Perera A, Fertig N, Lucas M et al (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56:2740–2746CrossRefPubMed Perera A, Fertig N, Lucas M et al (2007) Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum 56:2740–2746CrossRefPubMed
18.
Zurück zum Zitat Sandqvist G, Nilsson JÅ, Wuttge DM, Hesselstrand R (2014) Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis. J Rheumatol 41:2186–2192CrossRefPubMed Sandqvist G, Nilsson JÅ, Wuttge DM, Hesselstrand R (2014) Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis. J Rheumatol 41:2186–2192CrossRefPubMed
19.
Zurück zum Zitat Mouthon L, Carpentier PH, Lok C et al (2017) Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function. Semin Arthritis Rheum 46:759–766CrossRefPubMed Mouthon L, Carpentier PH, Lok C et al (2017) Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function. Semin Arthritis Rheum 46:759–766CrossRefPubMed
Metadaten
Titel
Investigating performance-based hand functions in patients with systemic sclerosis
verfasst von
Emre Alp Akatay
Deniz Bayraktar
Eda Otman
Oguz Ustun
Idil Kurut Aysin
Devrim Can Sarac
Busranur Atalay
Irem Ramazanoglu
Ilyas Tekin
Tugba Kurum
Sercan Gucenmez
Mustafa Ozmen
Servet Akar
Publikationsdatum
08.09.2022
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe Sonderheft 1/2024
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-022-01267-5

Weitere Artikel der Sonderheft 1/2024

Zeitschrift für Rheumatologie 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.